發(fā)布時間：2018-08-13 12:17

【摘要】：目的:觀察氟桂利嗪聯(lián)合丹參多酚酸鹽治療急性偏頭痛的療效和安全性。方法:72例急性偏頭痛患者隨機分為對照組(36例)和觀察組(36例)。在常規(guī)治療的基礎(chǔ)上,對照組患者口服鹽酸氟桂利嗪膠囊,65歲及以下每晚10 mg,每日1次,65歲以上每晚5 mg,每日1次;觀察組患者在對照組治療的基礎(chǔ)上給予注射用丹參多酚酸鹽200 mg,靜脈滴注,每日1次。兩組均連續(xù)治療至痊愈或連續(xù)治療2周。觀察兩組患者的臨床療效、起效時間、痊愈時間,治療前后視覺模擬疼痛(VAS)評分、發(fā)作頻率和持續(xù)時間及不良反應(yīng)發(fā)生情況。結(jié)果:治療過程中兩組均無患者終止、脫落,均完成治療。觀察組患者總有效率(97.22%)顯著高于對照組(86.11%),起效時間、痊愈時間均顯著短于對照組,差異均有統(tǒng)計學(xué)意義(P0.05)。治療前,兩組患者VAS評分、發(fā)作頻率、持續(xù)時間比較,差異均無統(tǒng)計學(xué)意義(P0.05)。治療后,兩組患者VAS評分、發(fā)作頻率、持續(xù)時間均顯著低于同組治療前,且觀察組顯著低于對照組,差異均有統(tǒng)計學(xué)意義(P0.05)。兩組患者不良反應(yīng)發(fā)生率比較,差異無統(tǒng)計學(xué)意義(P0.05)。結(jié)論:在常規(guī)治療的基礎(chǔ)上,氟桂利嗪聯(lián)合丹參多酚酸鹽治療急性偏頭痛的療效與安全性均較好。
[Abstract]:Objective: to observe the efficacy and safety of flunarizine combined with salvia miltiorrhiza polyphenolic acid in the treatment of acute migraine. Methods 72 patients with acute migraine were randomly divided into control group (36 cases) and observation group (36 cases). On the basis of routine treatment, the patients in the control group were treated with flunarizine hydrochloride capsules (10 mg / night) and 5 mg / day (5 mg / day). The patients in the observation group were treated with 200 mg salvia miltiorrhiza polyphenolic acid for injection on the basis of treatment in the control group. Both groups were treated continuously until recovery or 2 weeks of continuous treatment. The clinical efficacy, onset time, recovery time, (VAS) score of visual analogue pain, attack frequency, duration and adverse reactions were observed before and after treatment. Results: in the course of treatment, no patients in both groups were terminated, abscission and treatment was completed. The total effective rate (97.22%) in the observation group was significantly higher than that in the control group (86.11%). The onset time and recovery time were significantly shorter than those in the control group (P0.05). Before treatment, there was no significant difference in VAS score, attack frequency and duration between the two groups (P0.05). After treatment, the VAS score, attack frequency, duration of the two groups were significantly lower than the same group before treatment, and the observation group was significantly lower than the control group, the difference was statistically significant (P0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion: flunarizine combined with salvia miltiorrhiza polyphenolic acid is effective and safe in the treatment of acute migraine.
【作者單位】： 南華大學(xué)附屬第二醫(yī)院臨床藥學(xué)科;南華大學(xué)附屬第二醫(yī)院重癥醫(yī)學(xué)科;南華大學(xué)藥學(xué)與生命科學(xué)院;南華大學(xué)附屬第二醫(yī)院藥劑科;南華大學(xué)附屬第二醫(yī)院內(nèi)分泌科;
【基金】：湖南省教育廳科學(xué)研究項目(No.16C1407)
【分類號】：R747.2

【參考文獻】

相關(guān)期刊論文 前10條

1 胡微;;苯甲酸利扎曲普坦聯(lián)合針灸治療急性發(fā)作期偏頭痛的臨床觀察[J];中國實用醫(yī)藥;2016年05期

2 毛燕;崔慧娟;王玉才;;救腦湯治療偏頭痛急性期(血瘀證)的療效及對中醫(yī)證候積分和血清LPA、TNF-α水平的影響[J];中國中醫(yī)急癥;2016年02期

3 翟亞川;姚杰;;針刺聯(lián)合天麻白術(shù)湯治療偏頭痛急性發(fā)作的臨床療效觀察[J];中國中醫(yī)急癥;2015年07期

4 曾明;邸曉輝;王金萍;;注射用丹參多酚酸鹽治療缺血性腦卒中療效與安全性的系統(tǒng)評價[J];中國實驗方劑學(xué)雜志;2015年05期

5 趙英召;尹廣;張娜;謝彩霞;趙爍;魏輝;付領(lǐng)然;穆倩;;偏頭痛的研究進展[J];臨床合理用藥雜志;2014年10期

6 廖美媛;樊光輝;;偏頭痛的中醫(yī)治療近況[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2014年02期

7 張曉雷;陳俊華;郭春霞;辛現(xiàn)良;;丹參多酚酸鹽的藥理作用研究[J];世界臨床藥物;2013年05期

8 彭雪梅;蔡敏;;偏頭痛患者的人格特征研究現(xiàn)狀[J];重慶醫(yī)學(xué);2013年12期

9 吳友良;羅艷梅;高軍;;不同劑量氟桂利嗪膠囊治療偏頭痛的臨床效果研究[J];中國藥業(yè);2012年23期

10 付莛凱;朱廣廷;王，

本文編號：2180965